Josh Makower, MD

General Partner, NEA
Chairman, ExploraMed Development
Consulting Professor, Stanford University School of Medicine

[Josh Makower, MD @joshatstanford]

My band, Still Trust, has just released our first live album!
Available now on all the major streaming platforms:
https://t.co/LBIDuUIGZj
We'll be performing next at The Bitter End in NYC on April 29th, 2023 at 9:30PM. Tickets are available now at:
https://t.co/kNfkCRtmVA

[Stanford Biodesign @SUBiodesign]

At the 24th Annual Thomas J. Fogarty, MD Lecture, Mir Imran shared lessons from his 40-year career developing breakthrough health innovations that have helped millions of people. Thank you @StanfordSurgery and @FogartyInnov for supporting this program with us!

[Stanford Biodesign @SUBiodesign]

Joe Knight, President and CEO of InnAVasc cites his Biodesign Innovation Fellowship as the foundation and the core of his career. “I am a better innovator and executive because of the time spent at Stanford Biodesign. @WLGore recentally acquired InnAVasc Medical, Inc.

[Stanford Biodesign @SUBiodesign]

Ready to invent your future? Applications for the 2023-24 Stanford Biodesign Innovation Fellowship are now OPEN! Learn more about this once in a lifetime opportunity here: https://t.co/wGHdLpIDmi #healthteach #innovation #training”

[Josh Makower, MD @joshatnea]

My Band, Still Trust, will play @BitterEndNYC on Saturday, June 11th at 9 PM. Buy your tickets now to get preferred seating here: https://t.co/gOKPcd40xh

[Josh Makower, MD @joshatnea]

Still Trust will play The Bitter End in NYC on Saturday November 13th, 2021 at 8pm. First time we've been together since the pandemic cancelled our last performance in March 2020. All are welcome - proof of vaccination required for admission.

[Josh Makower, MD @joshatnea]

@SUBiodesign @joshatstanford Awesome work everyone! We might be 20 years in, but this is just the beginning of our journey to advance innovation, education, and equity in the service of advancing health.

[Stanford Biodesign @SUBiodesign]

Biodesign 2.0 Offsite! With creative help from Paulo Simas, we gathered at Casa @joshatstanford to revisit our purpose by examining the problems we are trying to solve, the three things we do daily to achieve those goals, and how we define our relevance, reach, and results.

[Josh Makower @JoshAtCoravin]

Still Trust will perform at The Bitter End in NYC on November 13th at 8pm! And yes, we all still look exactly like this! ⁦@BitterEndNYC⁩ ⁦@EvanKremin⁩ ⁦@joshatnea⁩ ⁦@joshatstanford⁩ ⁦@SUBiodesign⁩ ⁦@NEA⁩ ⁦@exploramed⁩

[Fogarty Innovation @FogartyInnov]

Tune in to part 2 of our podcast with @joshatstanford, as he discusses his experience working at Pfizer, breaking new ground by launching @ExploraMed
and coming full circle as co-founder and now director of
@SUBiodesign. Listen to the podcast: https://t.co/M0v7Tw5LAg

[Stanford Biodesign @SUBiodesign]

Don't miss part 2! @FogartyInnov CEO Andrew Cleeland interviews @joshatnea, an engineer, physician, serial medtech entrepreneur, venture capitalist, musician, artist, wine connoisseur, and the new director of Stanford Biodesign. #medtechtrailblazers https://t.co/eOsbvNLhBv

[Fogarty Innovation @FogartyInnov]

Tune in to this week’s podcast as @joshatnea, incoming director of @SUBiodesign, talks about his journey from MIT and medical school to becoming a quintessential #entrepreneur: https://t.co/QbLJNz37IU #medtech @NEA

[Fogarty Innovation @FogartyInnov]

“One of the greatest thrills in life is to do something that's never been done before. It’s about breaking new ground and improving outcomes for patients.” Watch the 1st #MedTechTrailblazers episode with
@joshatnea, incoming director of @SUBiodesign: https://t.co/3KGO5uIifC

[MedTech Strategist | MedTech's Most Trusted Source @MedTechStrat]

Congratulations to @exploramed, the new director of @SUBiodesign. Earlier this summer, he spoke with @DCassak about his plans for the center. Read the @MedTechStrat interview here (free). https://t.co/pFpPknZXBG

[Stanford Biodesign @SUBiodesign]

Learn why staying focused on the need and the customer leads to the next big innovative idea, what's wrong with reimbursement, and a new #healthtech policy focus for @SUBiodesign in @DeviceTalks with @joshatnea! @MedTechTom @newmarker @exploramed
https://t.co/Jlv8YFi0br

[NEA @NEA]

We're always proud of @joshatnea and his dedication to developing new tech to advance patient care. We're excited to continue building companies together as he assumes leadership of the @SUBiodesign program he co-founded more than 20yrs ago. Congrats Josh! https://t.co/ZJKrUzVwaV

[Stanford Biodesign @SUBiodesign]

CONGRATULATIONS and welcome back @joshatnea! We're excited to welcome you as the new director of Stanford Biodesign starting August 1. More details in a news story coming tomorrow, stay tuned! @exploramed @JoshAtCoravin #healthtech #innovation #training

[Stanford Biodesign @SUBiodesign]

“Hearing that Josh was interested in the director position was like finding out Steph Curry is eligible to play on your college basketball team. We're delighted to welcome him back to Stanford Biodesign.” @PaulYockMD @joshatnea @exploramed @JoshAtCoravin https://t.co/l9b96K7Tsh

[NEA @NEA]

🎉In today's ambiguous acronym news, NEA's own Josh Makower has been elected to the NAE--one of the highest honors accorded an engineer! Investor, inventor, founder, author... we're just glad to call endlessly talented @joshatnea our partner & friend. https://t.co/iMzhBLLcre

[Scott Gottlieb, MD 🇺🇸 @ScottGottliebMD]

Feds should option next tranche of J&J vaccine; as hedge against need for supply and in anticipation that J&J jab could turn into 2-dose vaccine or patients may opt for boosters after 2-dose data is revealed. If we have excess we can donate, starting with sharing more with Mexico